Shukra Pharmaceuticals
add_icon

Shukra Pharmaceuticals

39.90
-0.75
(-1.85%)
Market Cap
1,747.16 Cr
PE Ratio
60.67
Volume
69,949.00
Day High - Low
41.59 - 39.16
52W High-Low
65.26 - 11.74
ann
There are new updates from the company23 hrs ago
Viewcross
right
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
1,747.16 Cr
EPS
0.22
PE Ratio
60.67
PB Ratio
162.60
Book Value
0.25
EBITDA
16.90
Dividend Yield
0.02 %
Industry
Healthcare
Return on Equity
15.24
Debt to Equity
0.06
Forecast For
Actual

Company News

View All News
Caret
neutral
Shukra Pharmaceuticals conducted its mandatory independent directors meeting on March 16, 2026, reviewing board performance and information flow as per regulatory requirements.
positive
Shukra Pharmaceuticals reports exceptional Q3FY26 performance with net profit jumping 543% to ₹2,036.46 lakhs and revenue growing 270% YoY. Nine-month profits soar 467% to ₹2,377.46 lakhs.
positive
Shukra Pharmaceuticals allots 46,43,000 convertible equity warrants to promoters at ₹34 per warrant, raising ₹3.95 crore upfront with potential total of ₹15.79 crore.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,786.80
#1 4,28,713.17
39.05
#1 54,729.00
9.71
#1 10,980
16.07
56.64
6,063.00
1,60,953.60
65.06
9,712.00
18.67
2,191
-1.02
38.37
4,279.70
1,44,844.49
63.50
11,539.40
6.99
1,911
26.24
49.65
1,268.10
1,05,839.48
19.27
33,741.20
16.73
5,725
-15.28
47.81
2,292.40
1,04,716.56
22.42
22,909.50
13.74
3,306
#1 37.44
53.17
1,277.10
1,03,160.54
23.14
28,409.50
7.12
5,291
-57.18
36.50
891.10
89,665.51
#1 17.74
23,511.00
18.55
4,615
-0.32
42.14
2,077.50
85,760.25
47.89
12,744.20
#1 20.90
2,007
7.65
43.63
1,278.50
74,255.49
21.32
32,345.60
9.43
3,484
7.59
61.70
5,321.00
63,620.54
26.27
13,458.30
3.70
2,216
1.90
39.37
Growth Rate
Revenue Growth
-52.45 %
Net Income Growth
-48.11 %
Cash Flow Change
252.31 %
ROE
-52.61 %
ROCE
-36.69 %
EBITDA Margin (Avg.)
60.33 %

Quarterly Financial Results

Quarterly Financials
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
12
15
7
8
40
Expenses
7
6
4
6
12
EBITDA
5
9
2
1
28
Operating Profit %
37 %
55 %
24 %
-7 %
69 %
Depreciation
1
1
1
1
1
Interest
0
0
0
0
0
Profit Before Tax
4
8
1
0
27
Tax
1
2
0
-2
7
Net Profit
3
5
1
2
20
EPS in ₹
0.72
0.12
0.02
0.05
0.47

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
18
17
19
24
28
34
36
35
75
78
87
Fixed Assets
10
10
10
14
16
17
18
18
20
20
19
Current Assets
7
6
7
8
11
15
16
16
53
56
65
Capital Work in Progress
2
2
2
2
2
2
2
2
2
2
2
Investments
0
0
0
0
0
0
0
0
0
0
0
Other Assets
7
6
7
8
11
15
16
16
53
56
65
Total Equity & Liabilities
18
17
19
24
28
34
36
35
75
78
87
Current Liabilities
1
1
2
3
4
7
7
12
43
14
17
Non Current Liabilities
4
3
3
6
9
11
13
6
7
6
7
Total Equity
14
14
15
15
15
15
16
16
25
58
63
Reserve & Surplus
12
13
13
13
14
14
14
15
21
47
19
Share Capital
2
2
2
2
2
2
2
2
4
11
44

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
0
1
-1
-1
0
-0
0
-0
4
6
2
Investing Activities
1
-0
-1
-5
-3
-3
-2
-2
-4
-1
-1
Operating Activities
-2
3
-0
1
0
1
1
8
3
-5
8
Financing Activities
1
-1
0
4
2
2
2
-7
5
12
-5

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Aug 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
49.17 %
49.17 %
49.17 %
49.17 %
49.17 %
49.17 %
49.17 %
49.17 %
50.90 %
50.90 %
50.90 %
50.90 %
50.96 %
50.96 %
50.96 %
50.96 %
50.96 %
50.96 %
50.96 %
50.96 %
50.96 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.80 %
0.80 %
0.80 %
0.80 %
0.80 %
0.80 %
0.80 %
0.80 %
0.11 %
0.11 %
0.11 %
0.11 %
0.11 %
0.11 %
0.11 %
0.11 %
0.11 %
0.11 %
0.11 %
0.11 %
0.11 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
33.02 %
33.02 %
32.90 %
32.86 %
32.83 %
32.81 %
33.00 %
33.06 %
29.14 %
29.10 %
29.11 %
29.14 %
28.94 %
9.79 %
9.19 %
9.25 %
9.41 %
9.29 %
28.69 %
9.20 %
9.43 %
Others
17.01 %
17.01 %
17.14 %
17.18 %
17.21 %
17.22 %
17.04 %
16.98 %
19.85 %
19.88 %
19.88 %
19.85 %
19.99 %
39.14 %
39.73 %
39.68 %
39.51 %
39.64 %
20.24 %
39.72 %
39.50 %
No of Share Holders
9,345
9,345
9,305
9,268
9,239
9,193
9,237
9,234
9,544
9,582
9,600
9,747
10,963
12,974
14,989
16,321
17,844
18,231
20,337
21,441
25,649

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.5 0.5 0.5 0.00 0.00 0.5 0.5 1 0.01 0.00
Dividend Yield (%) 156.25 263.16 208.33 0.00 0.00 42.74 6.13 4.58 0.02 0.00

Announcements

Board Meeting Outcome for Independent Directors Meeting23 hrs ago
Board Meeting Intimation for Independent Directors Meeting10 days ago
Newspaper Publication Of Standalone And Consolidated Un-Audited Financial Results For Quarter And Nine Month Ended 31St December 2025Feb 05, 2026
Unaudited Financial Results For The Quarter Ended December 2025Feb 04, 2026
Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On Wednesday February 04 2026Feb 04, 2026
Update on board meetingJan 30, 2026
Board Meeting Intimation for Unaudited Financial Result For The Third Quarter Ended On 31 December 2025 Along With The Auditors Limited Review Report.Jan 30, 2026
Announcement under Regulation 30 (LODR)-AllotmentJan 28, 2026
Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On TodayJan 28, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 07, 2026
Voting Result Along With Scrutinizer Report Of Postal BallotJan 05, 2026
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsJan 05, 2026
Reconstitution Of Committees Of The Company.Dec 30, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementDec 30, 2025
Announcement under Regulation 30 (LODR)-Resignation of DirectorDec 30, 2025
Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Held On December 30 2025.Dec 30, 2025
Closure of Trading WindowDec 23, 2025
Intimation For Corporate Announcement Under Regulation 30 Of SEBI (LODR) Regulations Working In The Government Market Of Gujarat For Our Laparoscopic Sets And Accessories.Dec 22, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 05, 2025
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderDec 03, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotDec 03, 2025
Approval Of Continuation Of Directorship Of Mr. Jitendra Somchand Shah Non-Executive Independent Director Who Has Attained Age Of 75 Years On September 22 2025 Subject To Approval Of Shareholders.Nov 29, 2025
Outcome Of The Meeting Of The Board Of Directors Held On Saturday November 29 2025Nov 29, 2025
Board Meeting Outcome for Outcome Of The Meetins Of The Board Of Directors Held On Saturdav. November 29.2025.Nov 29, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 14, 2025
Un-Audited Financial Results Of The Company For The Second Quarter And Half Year Ended September 30 2025 Along With The Auditors Limited Review Reports In Accordance With The Provisions Of Regulation 33 Of The SEBI Listing Regulations.Nov 13, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On November 13 2025.Nov 13, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Incorporation Of Subsidiary Company.Nov 10, 2025
Voting Result Along With Scrutinizer Report Of Extra Ordinary General Meeting (EOGM) Of The Company Held On November 01 2025.Nov 01, 2025
Shareholder Meeting / Postal Ballot-Outcome of EGMNov 01, 2025
Board Meeting Intimation for Unaudited Financial Result For The Half Year Ended On 30TH September 2025 Along With The Auditors Limited Review Report.Oct 31, 2025
Receipt Of Distributorship RightsOct 31, 2025
Intimation U/R 30 Of SEBI LODR- Incorporation Of Subsidiary CompanyOct 24, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 15, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Authorization Received From Meril Healthcare Private Limited For The Project Of ROBOTIC ASSISTED SURGERY SYSTEM FOR ORTHOPEDICS At Directorate General Armed Forces Medical Services And INHS Asvini Maharashtra.Oct 08, 2025
Notice Of Extra Ordinary General Meeting Of Shukra Pharmaceuticals Limited To Be Held On Saturday November 01 2025.Oct 07, 2025
Board Meeting Outcome for Revised Outcome Of The Meeting Of The Board Of Directors Held On Friday October 03 2025.Oct 04, 2025
Announcement under Regulation 30 (LODR)-Issue of SecuritiesOct 03, 2025
Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On Friday October 03 2025.Oct 03, 2025
Voting Result Along With Scrutinizer Report Of 32Nd Annual General Meeting (AGM) Of The Company Held On September 30 2025.Oct 03, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 30, 2025
Closure of Trading WindowSep 29, 2025
Board Meeting Intimation for Preferential Issue Of Warrants As Per Chapter V And In Accordance With Securities And Exchange Board Of India (Issue Of Capital And Disclosure Requirements) Regulations 2018 To Promoters Subject To Approval Of Shareholders.Sep 22, 2025
Intimation Of Book Closure And Record Date Pursuant To Regulation 42 Of SEBI Listing Regulations For Annual General Meeting Of The Company.Sep 12, 2025
Intimation Of Record Date For Final Dividend For Financial Year 2024-2025.Sep 12, 2025
Corrigendum To The Notice Of 32ND Annual General Meeting And Annual Report (2024-25) Of The CompanySep 12, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 10, 2025
Announcement Under Regulation 30 Of SEBI (LODR)- Strategic PAN India Distribution Tie-UpSep 10, 2025
Reg. 34 (1) Annual Report.Sep 08, 2025

Technical Indicators

RSI(14)
Neutral
48.14
ATR(14)
Volatile
2.68
STOCH(9,6)
Neutral
48.80
STOCH RSI(14)
Neutral
59.39
MACD(12,26)
Bullish
0.27
ADX(14)
Weak Trend
11.13
UO(9)
Bearish
47.60
ROC(12)
Uptrend But Slowing Down
4.04
WillR(14)
Neutral
-41.86